02/14/2025
5:03 AM | Mineralys Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
5:03 AM | ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
4:29 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
7:05 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
8:44 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
8:45 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
8:46 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
5:21 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:34 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MLYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/07/2025
4:58 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:37 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:40 AM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
5:43 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
7:03 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
3:21 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:48 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:54 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
3:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:20 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:45 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:50 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
5:34 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:41 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:37 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:39 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
3:53 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
4:44 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:39 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:14 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:33 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:31 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
5:15 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
06/14/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
4:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:33 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
3:50 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
5:51 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:38 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:43 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:14 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:10 AM | Mineralys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
3:24 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
11:15 PM | Mineralys Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:35 PM | Mineralys Therapeutics (Filer)
| Form 424B5 | |
04/09/2024
6:15 AM | Mineralys Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
6:18 AM | Mineralys Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024
6:21 AM | Mineralys Therapeutics (Filer)
| Form ARS | |
04/04/2024
7:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:44 PM | Mineralys Therapeutics (Filer)
| Form S-3/A | |
03/21/2024
6:43 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:30 AM | Mineralys Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/21/2024
6:14 AM | Mineralys Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
4:35 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
